Click Therapeutics
About:
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Website: http://www.clicktherapeutics.com
Twitter/X: click_tx
Top Investors: Accelmed, Silicon Valley Bank, Revelation Partners, HSBC Innovation Banking, Health Catalyst Capital
Description:
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
$946M
$1M to $10M
New York, New York, United States
2012-04-01
Info(AT)clicktherapeutics.com
Bruce Leuchter, David Benshoof Klein, Victor Gao
101-250
2023-11-06
Private
© 2025 bioDAO.ai